Investors pile into CANbridge stock but can the rally last? 北海康成完成1億港元戰略定增 兩個半月股價飆漲逾15倍
The maker of drugs for rare diseases has enjoyed an explosive rise in its share price, helped by a partnership deal and Chinese moves to widen access to costly therapies 罕見病賽道存在患者基數天花板與支付體系瓶頸，需警惕短期估值泡沫風險。
Bamboo Works (official website) provides news on Chinese companies listed in Hong Kong and the United States, with a strong focus on mid-cap and also pre-IPO companies.